- Home
- VIRC vs ATOS Comparison
VIRC vs ATOS Comparison
Compare VIRC & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRC
- ATOS
- Stock Information
- Founded
- VIRC 1950
- ATOS 2009
- Country
- VIRC United States
- ATOS United States
- Employees
- VIRC N/A
- ATOS N/A
- Industry
- VIRC Industrial Specialties
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- VIRC Consumer Discretionary
- ATOS Health Care
- Exchange
- VIRC Nasdaq
- ATOS Nasdaq
- Market Cap
- VIRC 121.8M
- ATOS 107.2M
- IPO Year
- VIRC N/A
- ATOS 2012
- Fundamental
- Price
- VIRC $8.47
- ATOS $0.78
- Analyst Decision
- VIRC
- ATOS Strong Buy
- Analyst Count
- VIRC 0
- ATOS 3
- Target Price
- VIRC N/A
- ATOS $6.17
- AVG Volume (30 Days)
- VIRC 59.3K
- ATOS 1.3M
- Earning Date
- VIRC 09-08-2025
- ATOS 08-12-2025
- Dividend Yield
- VIRC 1.18%
- ATOS N/A
- EPS Growth
- VIRC N/A
- ATOS N/A
- EPS
- VIRC 1.25
- ATOS N/A
- Revenue
- VIRC $253,259,000.00
- ATOS N/A
- Revenue This Year
- VIRC $0.81
- ATOS N/A
- Revenue Next Year
- VIRC $4.56
- ATOS N/A
- P/E Ratio
- VIRC $6.80
- ATOS N/A
- Revenue Growth
- VIRC N/A
- ATOS N/A
- 52 Week Low
- VIRC $7.47
- ATOS $0.55
- 52 Week High
- VIRC $18.50
- ATOS $1.66
- Technical
- Relative Strength Index (RSI)
- VIRC 57.36
- ATOS 45.59
- Support Level
- VIRC $7.91
- ATOS $0.81
- Resistance Level
- VIRC $8.31
- ATOS $0.80
- Average True Range (ATR)
- VIRC 0.29
- ATOS 0.03
- MACD
- VIRC 0.02
- ATOS -0.00
- Stochastic Oscillator
- VIRC 80.25
- ATOS 39.58
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.